Medicare Enrolled
Dr. Prashant Patel, MD
Hematology & Oncology · Stuart, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Prashant Patel is a hematology & oncology in Stuart, FL, with 20 years in practice. Based on federal Medicare data, Dr. Patel performed 123,737 Medicare services across 3,099 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $45,090 from 102 pharmaceutical and/or device companies across 1843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 5% volume in FL$ $45,090 industry payments
Medicare Practice Summary
Medicare Utilization ↗123,737
Medicare services
Top 5% in FL for hematology & oncology
3,099
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,187 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 46,500 | $1 | $3 |
| Iron infusion (Feraheme) | 26,010 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 23,800 | $43 | $107 |
| Epoetin alfa injection (Retacrit) for anemia | 7,200 | $6 | $22 |
| Dexamethasone injection (steroid) | 6,016 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 3,540 | $18 | $38 |
| Complete blood count (CBC) with differential | 1,876 | $8 | $40 |
| Office visit, established patient (30-39 min) | 1,003 | $101 | $175 |
| Comprehensive metabolic blood panel | 989 | $10 | $40 |
| Anti-nausea injection (ondansetron/Zofran) | 608 | $0 | $3 |
| Administration of chemotherapy into vein, 1 hour or less | 546 | $107 | $330 |
| Drug injection, under skin or into muscle | 512 | $11 | $45 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 470 | $24 | $76 |
| Infusion, normal saline solution, 250 cc | 451 | $0 | $6 |
| Ferritin level test (iron stores) | 349 | $13 | $27 |
| Folic acid level test | 348 | $14 | $29 |
| Vitamin B-12 level test | 345 | $15 | $30 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 341 | $52 | $150 |
| Injection, diphenhydramine hcl, up to 50 mg | 189 | $1 | $8 |
| Injection, zoledronic acid, 1 mg | 188 | $6 | $12 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 185 | $1 | $5 |
| Office visit, established patient (20-29 min) | 169 | $70 | $111 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 145 | $338 | $1,111 |
| Carcinoembryonic antigen (cea) protein level | 133 | $19 | $38 |
| New patient office visit (45-59 min) | 132 | $130 | $300 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 131 | $59 | $135 |
| Infusion into a vein for hydration, 31-60 minutes | 126 | $26 | $125 |
| Administration of chemotherapy into vein, each additional hour | 117 | $23 | $78 |
| Hospital follow-up visit, high complexity | 116 | $98 | $185 |
| Administration of additional new drug or substance into vein, 1 hour or less | 113 | $53 | $165 |
| Thyroid stimulating hormone (TSH) test | 111 | $16 | $34 |
| Telephone medical discussion with physician, 5-10 minutes | 108 | $28 | $100 |
| Injection of additional new drug or substance into vein | 103 | $13 | $56 |
| Initial hospital admission, high complexity | 90 | $142 | $330 |
| Infusion into a vein for hydration, each additional hour | 87 | $11 | $40 |
| Magnesium level test | 83 | $7 | $15 |
| Lactate dehydrogenase (enzyme) level | 68 | $6 | $15 |
| PSA test (prostate cancer screening) | 67 | $18 | $37 |
| Blood draw (venipuncture) | 58 | $8 | $15 |
| Hospital follow-up visit, moderate complexity | 51 | $65 | $130 |
| Phosphate level test | 46 | $5 | $11 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 45 | $28 | $68 |
| Irrigation of implanted venous access drug delivery device | 33 | $16 | $54 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $55 | $105 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 26 | $20 | $42 |
| Stool analysis for blood to screen for colon tumors | 25 | $4 | $10 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 17 | $20 | $42 |
| Office visit, established patient, complex (40-54 min) | 17 | $148 | $251 |
| Initial hospital admission, moderate complexity | 13 | $105 | $250 |
| New patient office visit, complex (60-74 min) | 11 | $184 | $364 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
59.8% high complexity
35.0% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,090
Total received (2018-2024)
Avg $6,441/year across 7 years
Top 15% in FL for hematology & oncology
102
Companies
1,843
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,294 (71.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,484 (23.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,311 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,677
2023$6,305
2022$5,749
2021$4,558
2020$3,259
2019$5,177
2018$14,365
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bayer HealthCare Pharmaceuticals Inc.
$10,900
PFIZER INC.
$2,617
AstraZeneca Pharmaceuticals LP
$2,534
Janssen Biotech, Inc.
$2,522
Amgen Inc.
$1,530
GENZYME CORPORATION
$1,474
E.R. Squibb & Sons, L.L.C.
$1,472
Novartis Pharmaceuticals Corporation
$1,415
Genentech USA, Inc.
$1,322
Astellas Pharma US Inc
$1,295
Celgene Corporation
$1,223
Lilly USA, LLC
$1,100
Incyte Corporation
$1,065
Regeneron Healthcare Solutions, Inc.
$904
Merck Sharp & Dohme Corporation
$873
GlaxoSmithKline, LLC.
$798
Ipsen Biopharmaceuticals, Inc
$665
Daiichi Sankyo Inc.
$618
Seagen Inc.
$581
ABBVIE INC.
$494
Takeda Pharmaceuticals U.S.A., Inc.
$446
Dova Pharmaceuticals
$418
Boehringer Ingelheim Pharmaceuticals, Inc.
$402
Mirati Therapeutics, Inc.
$363
Rigel Pharmaceuticals, Inc.
$334
Merck Sharp & Dohme LLC
$326
Kite Pharma, Inc.
$319
Exelixis Inc.
$310
Gilead Sciences, Inc.
$297
Karyopharm Therapeutics Inc.
$287
Pharmacyclics LLC, An AbbVie Company
$265
JAZZ PHARMACEUTICALS INC.
$240
Sun Pharmaceutical Industries Inc.
$230
Coherus Biosciences Inc.
$205
AMAG Pharmaceuticals, Inc.
$203
ARRAY BIOPHARMA INC
$202
Foundation Medicine, Inc.
$200
SUN PHARMACEUTICAL INDUSTRIES INC.
$192
Tempus AI, Inc
$185
BeiGene USA, Inc.
$184
Medtronic, Inc.
$175
Taiho Oncology, Inc.
$166
AVEO Pharmaceuticals, Inc.
$164
SOBI, INC
$151
Puma Biotechnology, Inc.
$144
Kyowa Kirin, Inc.
$144
Heron Therapeutics, Inc.
$137
Eisai Inc.
$131
Pharmacyclics LLC, an AbbVie Company
$130
AbbVie Inc.
$127
SANOFI-AVENTIS U.S. LLC
$124
Celltrion USA Inc.
$114
Boston Scientific Corporation
$114
Bayer Healthcare Pharmaceuticals Inc.
$110
Alexion Pharmaceuticals, Inc.
$96
PUMA BIOTECHNOLOGY, INC.
$89
Tolmar, Inc.
$88
Pharmacosmos Therapeutics Inc.
$84
EMD Serono, Inc.
$82
AbbVie, Inc.
$81
Mylan Institutional Inc.
$81
ADC Therapeutics America, Inc.
$80
Sobi, Inc
$80
TESARO, Inc.
$79
Fennec Pharmaceuticals, Inc.
$79
Verastem, Inc.
$67
Secura Bio, Inc.
$61
TAIHO ONCOLOGY, INC.
$59
EISAI INC.
$59
PharmaEssentia USA Corporation
$57
Agios Pharmaceuticals, Inc.
$52
MEDIVATION FIELD SOLUTIONS LLC
$49
Blueprint Medicines Corporation
$46
Seattle Genetics, Inc.
$44
TOLMAR Pharmaceuticals, Inc.
$43
ACCORD HEALTHCARE, INC.
$40
Aurobindo Pharma USA, Inc.
$40
TerSera Therapeutics LLC
$39
Lexicon Pharmaceuticals, Inc.
$37
G1 Therapeutics, Inc.
$37
GE HEALTHCARE
$36
Emmaus Medical, Inc.
$34
Deciphera Pharmaceuticals Inc.
$33
Organon LLC
$32
Myriad Genetic Laboratories, Inc.
$31
Midatech Pharma US Inc
$31
SpringWorks Therapeutics, Inc.
$25
Organon Llc
$24
Biocon Biologics Inc
$24
Octapharma USA, Inc.
$24
SERVIER PHARMACEUTICALS LLC
$23
Dendreon Pharmaceuticals LLC
$21
Azurity Pharmaceuticals, Inc.
$20
Acrotech Biopharma Inc.
$18
Stemline Therapeutics Inc.
$18
Array BioPharma Inc.
$17
MorphoSys, US Inc.
$17
RECORDATI_RARE_DISEASES_INC.
$16
Janssen Pharmaceuticals, Inc
$16
Advanced Accelerator Applications
$14
Jazz Pharmaceuticals Inc.
$14
Shire North American Group Inc
$11
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Endari · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · FRUZAQLA · Farydak · Fulphila · GAZYVA · GILOTRIF · Gazyva · Gelclair · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron · Lupron Depot · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · OPDIVO · OPDUALAG · OSTEOCOOL RF ABLATION SYSTEM · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUNOSI · SUSTOL · SUTENT · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trodelvy · ULTOMIRIS · Udenyca · VEGZELMA · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · Vectibix · Venclexta · Vitrakvi · WATCHMAN FLX · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · XYREM · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zuplenz · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $36 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
18
Per 100K population
11.2
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and high industry engagement (low-engagement, top 15%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Patel performed 46,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $45,090 from 102 companies across 1,843 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematology & oncologys in Stuart?
Dr. Patel's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Stuart
Browse hematology & oncologys in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology